Serono News
Most Popular Serono Story
UCB to acquire Schwarz in latest buyout deal
Belgium's UCB is buying Germany's Schwarz Pharma for about $5.6 billion, the third major drug company deal in Germany in five days. Together, the two companies will enjoy about €3.3 billion in revenue and an R&D budget of €770 million. The merger will position the company to play partner with others in drug development around the world. According to UCB, "the enlarged UCB would be a more attractive partner for licensing deals and R&D collaboration than either Schwarz …
Read more...Latest Headlines
- January 4, 2007
- January 3, 2007
- December 7, 2006
- November 26, 2006
- November 20, 2006
- November 19, 2006
- October 25, 2006
- October 15, 2006
- October 1, 2006
- September 27, 2006
- September 24, 2006
- September 20, 2006
- September 13, 2006
- August 17, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
